Showing 1,641 - 1,660 results of 9,603 for search 'significant ((((((shape decrease) OR (we decrease))) OR (mean decrease))) OR (small decrease))', query time: 0.53s Refine Results
  1. 1641

    Image 1_NK cell-derived extracellular vesicles enhance cytotoxicity and immune cell recruitment in non-small cell lung cancer.jpg by Joanna Palade (17712960)

    Published 2025
    “…Next, we examined the functional capabilities of patient NKEVs in organoid structures derived from primary tumor cells, finding that exposure to patient NKEVs resulted in a 40-45% decrease in organoid viability, and significantly lowered the cisplatin dose required to elicit cytotoxicity. …”
  2. 1642

    Table 8_NK cell-derived extracellular vesicles enhance cytotoxicity and immune cell recruitment in non-small cell lung cancer.xlsx by Joanna Palade (17712960)

    Published 2025
    “…Next, we examined the functional capabilities of patient NKEVs in organoid structures derived from primary tumor cells, finding that exposure to patient NKEVs resulted in a 40-45% decrease in organoid viability, and significantly lowered the cisplatin dose required to elicit cytotoxicity. …”
  3. 1643

    Table 4_NK cell-derived extracellular vesicles enhance cytotoxicity and immune cell recruitment in non-small cell lung cancer.xlsx by Joanna Palade (17712960)

    Published 2025
    “…Next, we examined the functional capabilities of patient NKEVs in organoid structures derived from primary tumor cells, finding that exposure to patient NKEVs resulted in a 40-45% decrease in organoid viability, and significantly lowered the cisplatin dose required to elicit cytotoxicity. …”
  4. 1644

    Table 6_NK cell-derived extracellular vesicles enhance cytotoxicity and immune cell recruitment in non-small cell lung cancer.xlsx by Joanna Palade (17712960)

    Published 2025
    “…Next, we examined the functional capabilities of patient NKEVs in organoid structures derived from primary tumor cells, finding that exposure to patient NKEVs resulted in a 40-45% decrease in organoid viability, and significantly lowered the cisplatin dose required to elicit cytotoxicity. …”
  5. 1645

    Table 2_NK cell-derived extracellular vesicles enhance cytotoxicity and immune cell recruitment in non-small cell lung cancer.xlsx by Joanna Palade (17712960)

    Published 2025
    “…Next, we examined the functional capabilities of patient NKEVs in organoid structures derived from primary tumor cells, finding that exposure to patient NKEVs resulted in a 40-45% decrease in organoid viability, and significantly lowered the cisplatin dose required to elicit cytotoxicity. …”
  6. 1646

    Table 1_NK cell-derived extracellular vesicles enhance cytotoxicity and immune cell recruitment in non-small cell lung cancer.xlsx by Joanna Palade (17712960)

    Published 2025
    “…Next, we examined the functional capabilities of patient NKEVs in organoid structures derived from primary tumor cells, finding that exposure to patient NKEVs resulted in a 40-45% decrease in organoid viability, and significantly lowered the cisplatin dose required to elicit cytotoxicity. …”
  7. 1647

    Image 2_NK cell-derived extracellular vesicles enhance cytotoxicity and immune cell recruitment in non-small cell lung cancer.jpg by Joanna Palade (17712960)

    Published 2025
    “…Next, we examined the functional capabilities of patient NKEVs in organoid structures derived from primary tumor cells, finding that exposure to patient NKEVs resulted in a 40-45% decrease in organoid viability, and significantly lowered the cisplatin dose required to elicit cytotoxicity. …”
  8. 1648

    Table 5_NK cell-derived extracellular vesicles enhance cytotoxicity and immune cell recruitment in non-small cell lung cancer.xlsx by Joanna Palade (17712960)

    Published 2025
    “…Next, we examined the functional capabilities of patient NKEVs in organoid structures derived from primary tumor cells, finding that exposure to patient NKEVs resulted in a 40-45% decrease in organoid viability, and significantly lowered the cisplatin dose required to elicit cytotoxicity. …”
  9. 1649
  10. 1650
  11. 1651
  12. 1652
  13. 1653

    Magnetic Fields Generated by Directed Ionic Flow by Lin Wang (11986)

    Published 2024
    “…Our experimental results reveal that the magnetic flux density is directly proportional to the current intensity and decreases with larger distances. Furthermore, it increases with the number of effective coils and decreases with larger conduit sizes, demonstrating the significant impact of conduit shape on the generated magnetic field. …”
  14. 1654

    Magnetic Fields Generated by Directed Ionic Flow by Lin Wang (11986)

    Published 2024
    “…Our experimental results reveal that the magnetic flux density is directly proportional to the current intensity and decreases with larger distances. Furthermore, it increases with the number of effective coils and decreases with larger conduit sizes, demonstrating the significant impact of conduit shape on the generated magnetic field. …”
  15. 1655
  16. 1656
  17. 1657

    Data Sheet 1_Diversity, functionality, and stability: shaping ecosystem multifunctionality in the successional sequences of alpine meadows and alpine steppes on the Qinghai-Tibet P... by Xin Jin (108988)

    Published 2025
    “…We further identify the primary environmental drivers of these changes and evaluate their collective impact on ecosystem multifunctionality. …”
  18. 1658

    <b>Seasonal Hydrology and Projected Landscape Changes Jointly Shape Future Water Quality in a Typical Watershed of the Three Gorges Reservoir Area</b> by Xiaojun Zhao (22390147)

    Published 2025
    “…Under future scenarios of aggravated landscape fragmentation, TN concentrations decreased while TOC and COD<sub>Mn</sub> concentrations significantly increased compared to the 2024 dry season. …”
  19. 1659
  20. 1660

    Data Sheet 1_Previous COVID-19 infection significantly reduces elastase levels in newly diagnosed pulmonary tuberculosis patients.pdf by Nancy Hilda Joseph (21837314)

    Published 2025
    “…Introduction<p>Tuberculosis (TB) is considered a risk factor for severe COVID-19 disease and the quality of life of patients co-infected with COVID-19 and TB is significantly impacted due to the nature of these diseases. …”